Hisamitsu Pharmaceutical Co., Inc. (TYO:4530)
4,153.00
-13.00 (-0.31%)
At close: Dec 5, 2025
TYO:4530 Ratios and Metrics
Market cap in millions JPY. Fiscal year is March - February.
Millions JPY. Fiscal year is Mar - Feb.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 | Feb '21 Feb 28, 2021 | 2016 - 2020 |
| Market Capitalization | 290,906 | 308,076 | 293,429 | 303,688 | 296,969 | 542,719 | Upgrade
|
| Market Cap Growth | -9.34% | 4.99% | -3.38% | 2.26% | -45.28% | 37.96% | Upgrade
|
| Enterprise Value | 183,073 | 196,769 | 173,093 | 157,504 | 157,000 | 411,562 | Upgrade
|
| Last Close Price | 4153.00 | 4163.94 | 3738.10 | 3615.63 | 3384.30 | 6011.37 | Upgrade
|
| PE Ratio | 15.37 | 14.16 | 21.01 | 25.86 | 30.75 | 58.67 | Upgrade
|
| Forward PE | 15.84 | 16.20 | 18.33 | 23.68 | 27.63 | 53.21 | Upgrade
|
| PS Ratio | 1.87 | 1.98 | 2.07 | 2.37 | 2.47 | 4.74 | Upgrade
|
| PB Ratio | 1.08 | 1.10 | 1.10 | 1.18 | 1.17 | 2.14 | Upgrade
|
| P/TBV Ratio | 1.12 | 1.14 | 1.14 | 1.19 | 1.18 | 2.16 | Upgrade
|
| P/FCF Ratio | 33.94 | 59.96 | 55.74 | 62.38 | 19.05 | 278.60 | Upgrade
|
| P/OCF Ratio | 17.57 | 16.42 | 16.13 | 23.86 | 15.47 | 102.61 | Upgrade
|
| EV/Sales Ratio | 1.18 | 1.26 | 1.22 | 1.23 | 1.31 | 3.59 | Upgrade
|
| EV/EBITDA Ratio | 7.19 | 7.80 | 9.44 | 9.52 | 11.50 | 27.90 | Upgrade
|
| EV/EBIT Ratio | 9.84 | 10.41 | 13.15 | 13.58 | 16.82 | 38.57 | Upgrade
|
| EV/FCF Ratio | 21.36 | 38.30 | 32.88 | 32.35 | 10.07 | 211.27 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.10 | 0.15 | 0.11 | 0.14 | 0.18 | 0.11 | Upgrade
|
| Debt / FCF Ratio | 0.28 | 0.75 | 0.40 | 0.47 | 0.16 | 0.82 | Upgrade
|
| Asset Turnover | 0.45 | 0.46 | 0.44 | 0.42 | 0.40 | 0.38 | Upgrade
|
| Inventory Turnover | 2.62 | 2.98 | 3.13 | 3.15 | 2.87 | 2.67 | Upgrade
|
| Quick Ratio | 3.21 | 3.73 | 3.66 | 4.15 | 5.61 | 5.83 | Upgrade
|
| Current Ratio | 3.87 | 4.32 | 4.22 | 4.68 | 6.22 | 6.59 | Upgrade
|
| Return on Equity (ROE) | 7.39% | 8.16% | 5.49% | 4.72% | 3.88% | 3.74% | Upgrade
|
| Return on Assets (ROA) | 3.28% | 3.52% | 2.56% | 2.35% | 1.94% | 2.20% | Upgrade
|
| Return on Capital (ROIC) | 4.11% | 4.28% | 3.11% | 2.80% | 2.28% | 2.63% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.30% | 6.40% | 4.70% | 4.30% | 3.40% | 4.00% | Upgrade
|
| Earnings Yield | 6.77% | 7.06% | 4.76% | 3.87% | 3.25% | 1.70% | Upgrade
|
| FCF Yield | 2.95% | 1.67% | 1.79% | 1.60% | 5.25% | 0.36% | Upgrade
|
| Dividend Yield | 2.17% | 2.07% | 2.27% | 2.32% | 2.48% | 1.39% | Upgrade
|
| Payout Ratio | 33.57% | 29.96% | 47.09% | 57.22% | 70.81% | 73.58% | Upgrade
|
| Buyback Yield / Dilution | 3.19% | 4.27% | 3.03% | 2.29% | 0.63% | 0.56% | Upgrade
|
| Total Shareholder Return | 5.36% | 6.33% | 5.30% | 4.62% | 3.11% | 1.95% | Upgrade
|
Updated Aug 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.